Accessibility Menu
Establishment Labs Stock Quote

Establishment Labs (NASDAQ: ESTA)

$69.00
(-0.2%)
-0.14
Price as of November 25, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$69.00
Daily Change
(-0.2%) $0.14
Day's Range
$67.37 - $72.34
Previous Close
$69.00
Open
$69.29
Beta
1.63
Volume
380
Average Volume
433,486
Market Cap
2B
Market Cap / Employee
$69.00M
52wk Range
$26.56 - $72.34
Revenue
-
Gross Margin
0.69%
Dividend Yield
N/A
EPS
-$2.85
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Establishment Labs Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
ESTA+51.48%+160.38%+21.08%+179%
S&P+13%+86.41%+13.26%+141%

Establishment Labs Company Info

Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It generates income from customers in Europe, the Middle East, Latin America, and Asia. The firm's products include Motiva Implants, Motiva Flora Tissue Expander, Motiva Ergonomix, and Motiva Ergonomix2. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Alajuela, Costa Rica.

News & Analysis

Financial Health

General

Q3 2025YOY Change
Revenue$53.78M33.7%
Gross Profit$37.70M46.6%
Gross Margin70.09%6.2%
Market Cap$1.19B6.3%
Market Cap / Employee$1.15M-19.7%
Employees1K32.4%
Net Income-$11.15M33.2%
EBITDA-$1.58M85.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$70.62M77.9%
Accounts Receivable$71.44M6.2%
Inventory88.630.9%

Liabilities

Q3 2025YOY Change
Long Term Debt$249.44M25.9%
Short Term Debt$11.72M921.0%

Ratios

Q3 2025YOY Change
Return On Assets-26.70%-1.2%
Return On Invested Capital-36.30%2.6%

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$13.19M3.1%
Operating Free Cash Flow-$11.33M6.0%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Book39.3922.1232.0352.1794.24%
Price to Sales8.037.076.966.36-20.38%
Price to Tangible Book Value57.3529.0647.90114.53226.94%
Enterprise Value to EBITDA-90.21-94.53-122.61-887.40603.21%
Return on Equity-236.7%-186.7%-261.2%-338.2%51.35%
Total Debt$225.29M$225.70M$231.12M$261.16M31.02%

No results found

No podcast episodes available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.